A new weight-loss medicine for adults with overweight or obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new weight-loss medicine called MDR-001 in adults who are overweight or have obesity. It aims to see if the medicine is safe and helps people lose weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your weight puts you in the obesity or overweight range, with at least one weight-related health issue like high blood pressure or sleep apnea.
- Your weight has been stable (not fluctuating more than 5%) for the past 3 months.
- You do not have diabetes or a history of suicidal thoughts or depression.
- You have not had major heart or brain events (like a heart attack or stroke) in the last 6 months.
- You agree to follow the study's rules about which weight-loss drugs you can use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.
This study tests a new medication called DA-302168S to help people lose weight. You may qualify if you're overweight or obese and meet certain health requirements.
This study tests an experimental drug called MDR-001 to see if it can help people with obesity or overweight lose weight. It may be an option for you if you have weight-related health issues like high blood sugar, high blood pressure, or fatty liver.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.